Taiwan · Delayed Price · Currency is TWD Acer Medical Statistics
Total Valuation
Acer Medical has a market cap or net worth of TWD 1.38 billion. The enterprise value is 1.22 billion.
| Market Cap | 1.38B |
| Enterprise Value | 1.22B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Acer Medical has 15.23 million shares outstanding.
| Current Share Class | 15.23M |
| Shares Outstanding | 15.23M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.78% |
| Owned by Institutions (%) | 0.58% |
| Float | 3.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.55 |
| PB Ratio | 8.85 |
| P/TBV Ratio | 9.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.14
| Current Ratio | 5.14 |
| Quick Ratio | 4.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,209.23 |
Financial Efficiency
Return on equity (ROE) is -14.14% and return on invested capital (ROIC) is -9.92%.
| Return on Equity (ROE) | -14.14% |
| Return on Assets (ROA) | -8.30% |
| Return on Invested Capital (ROIC) | -9.92% |
| Return on Capital Employed (ROCE) | -17.08% |
| Weighted Average Cost of Capital (WACC) | 8.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.35 |
| Inventory Turnover | 5.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.73% in the last 52 weeks. The beta is 0.70, so Acer Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -17.73% |
| 50-Day Moving Average | 93.50 |
| 200-Day Moving Average | 103.57 |
| Relative Strength Index (RSI) | 41.91 |
| Average Volume (20 Days) | 901 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acer Medical had revenue of TWD 70.47 million and -23.69 million in losses. Loss per share was -1.56.
| Revenue | 70.47M |
| Gross Profit | 46.24M |
| Operating Income | -26.60M |
| Pretax Income | -23.69M |
| Net Income | -23.69M |
| EBITDA | -25.91M |
| EBIT | -26.60M |
| Loss Per Share | -1.56 |
Balance Sheet
The company has 153.77 million in cash and no debt, with a net cash position of 153.77 million or 10.10 per share.
| Cash & Cash Equivalents | 153.77M |
| Total Debt | n/a |
| Net Cash | 153.77M |
| Net Cash Per Share | 10.10 |
| Equity (Book Value) | 155.77M |
| Book Value Per Share | 10.21 |
| Working Capital | 146.04M |
Cash Flow
In the last 12 months, operating cash flow was -23.96 million and capital expenditures -1.39 million, giving a free cash flow of -25.35 million.
| Operating Cash Flow | -23.96M |
| Capital Expenditures | -1.39M |
| Depreciation & Amortization | 575,000 |
| Net Borrowing | 2.50M |
| Free Cash Flow | -25.35M |
| FCF Per Share | -1.66 |
Margins
Gross margin is 65.62%, with operating and profit margins of -37.75% and -33.62%.
| Gross Margin | 65.62% |
| Operating Margin | -37.75% |
| Pretax Margin | -33.62% |
| Profit Margin | -33.62% |
| EBITDA Margin | -36.76% |
| EBIT Margin | -37.75% |
| FCF Margin | n/a |
Dividends & Yields
Acer Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.72% |
| FCF Yield | -1.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |